184 related articles for article (PubMed ID: 32332143)
21. Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [
Doot RK; Young AJ; Daube-Witherspoon ME; Alexoff D; Labban KJ; Lee H; Wu Z; Zha Z; Choi SR; Ploessl KH; Schubert EK; Lee H; Zhu L; Reddin JS; Karp JS; Kung H; Pryma DA
Nucl Med Biol; 2020; 86-87():1-8. PubMed ID: 32361089
[TBL] [Abstract][Full Text] [Related]
22. NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [
Kaloudi A; Lymperis E; Giarika A; Dalm S; Orlandi F; Barbato D; Tedesco M; Maina T; de Jong M; Nock BA
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137110
[TBL] [Abstract][Full Text] [Related]
23. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
24. Preliminary results of biodistribution and dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
[TBL] [Abstract][Full Text] [Related]
25. First-in-Humans Study of
Viitanen R; Moisio O; Lankinen P; Li XG; Koivumäki M; Suilamo S; Tolvanen T; Taimen K; Mali M; Kohonen I; Koskivirta I; Oikonen V; Virtanen H; Santalahti K; Autio A; Saraste A; Pirilä L; Nuutila P; Knuuti J; Jalkanen S; Roivainen A
J Nucl Med; 2021 Apr; 62(4):577-583. PubMed ID: 32817143
[TBL] [Abstract][Full Text] [Related]
26. Phase I Study of [
Gondry O; Xavier C; Raes L; Heemskerk J; Devoogdt N; Everaert H; Breckpot K; Lecocq Q; Decoster L; Fontaine C; Schallier D; Aspeslagh S; Vaneycken I; Raes G; Van Ginderachter JA; Lahoutte T; Caveliers V; Keyaerts M
J Nucl Med; 2023 Sep; 64(9):1378-1384. PubMed ID: 37474271
[TBL] [Abstract][Full Text] [Related]
27. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, preclinical, and initial clinical evaluation of integrin α
Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
[TBL] [Abstract][Full Text] [Related]
29. Prospective Evaluation of
Minamimoto R; Sonni I; Hancock S; Vasanawala S; Loening A; Gambhir SS; Iagaru A
J Nucl Med; 2018 May; 59(5):803-808. PubMed ID: 29084827
[No Abstract] [Full Text] [Related]
30. [
Rivera-Bravo B; Ramírez-Nava G; Mendoza-Figueroa MJ; Ocampo-García B; Ferro-Flores G; Ávila-Rodríguez MA; Santos-Cuevas C
Nucl Med Biol; 2021; 96-97():54-60. PubMed ID: 33831746
[TBL] [Abstract][Full Text] [Related]
31. FAPI-74 PET/CT Using Either
Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C
J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493
[No Abstract] [Full Text] [Related]
32.
Wang L; Bratanovic IJ; Zhang Z; Kuo HT; Merkens H; Zeisler J; Zhang C; Tan R; Bénard F; Lin KS
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838968
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution and radiation dose estimates for
Krebs S; Pandit-Taskar N; Reidy D; Beattie BJ; Lyashchenko SK; Lewis JS; Bodei L; Weber WA; O'Donoghue JA
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):677-685. PubMed ID: 30374529
[TBL] [Abstract][Full Text] [Related]
34. Preclinical Comparison of the
Koller L; Joksch M; Schwarzenböck S; Kurth J; Heuschkel M; Holzleitner N; Beck R; von Amsberg G; Wester HJ; Krause BJ; Günther T
J Nucl Med; 2023 Oct; 64(10):1654-1659. PubMed ID: 37934025
[TBL] [Abstract][Full Text] [Related]
35.
Zhang J; Tian Y; Li D; Niu G; Lang L; Li F; Liu Y; Zhu Z; Chen X
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2152-2162. PubMed ID: 31270559
[TBL] [Abstract][Full Text] [Related]
36. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.
Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M
J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439
[TBL] [Abstract][Full Text] [Related]
38. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution, Dosimetry, and Pharmacokinetics of
Izquierdo-Garcia D; Désogère P; Fur ML; Shuvaev S; Zhou IY; Ramsay I; Lanuti M; Catalano OA; Catana C; Caravan P; Montesi SB
J Nucl Med; 2023 May; 64(5):775-781. PubMed ID: 37116909
[TBL] [Abstract][Full Text] [Related]
40.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
